Previous 10 | Next 10 |
home / stock / hrtx / hrtx articles
The FDA has approved Heron Therapeutics Inc’s (NASDAQ:HRTX) supplemental New Drug Application for Zynrelef (bupivacaine and meloxic...
U.S. stocks traded higher, with the Nasdaq Composite gaining around 100 points on Wednesday. Shares of Textron Inc. (NYSE: TXT) rose during Wednes...
U.S. stock futures were lower this morning, with the Dow Jones futures falling around 100 points on Tuesday. Shares of Hewlett Packard Enterprise ...
U.S. stock futures were lower this morning, with the Dow Jones futures falling around 150 points on Monday. Shares of Harpoon Therapeutics, Inc.(N...
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 150 points on Wednesday. The Dow traded up 0.46% to 34,98...
Heron Therapeutics Inc (NASDAQ: HRTX) reported Q3 sales of $31.43 million, missing the consensus of $32.75 million. The company reported ...
Shares of Shapeways Holdings, Inc. (NASDAQ: SHPW) tumbled during Wednesday’s session following downbeat results. Shapeways Hldgs posted an ad...
U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 100 points on Wednesday. The Dow traded up 0.32% to 34,939.64 whi...
Shares of CorMedix Inc. (NASDAQ: CRMD) surged in pre-market trading as the company posted a narrower-than-expected third-quarter loss. Cormedix po...
News, Short Squeeze, Breakout and More Instantly...
Heron Therapeutics Inc. Company Name:
HRTX Stock Symbol:
NASDAQ Market:
Heron Therapeutics Inc. Website:
Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN") PR Newswire -The U.S. Food and Drug Administration ("FDA") assigned a Prescription Drug User Fee Act ("PDUFA") goal date of September 23, 2024 ...
Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle ("VAN") PR Newswire SAN DIEGO , May 29, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechn...
2024-05-27 10:45:03 ET Heron Therapeutics Inc (HRTX) HRTX is trading UP for the last 5 days, and it at trading at $2.86 with volume of 6,916,602 and a one day change of $0.02 (0.53%). Heron Therapeutics Inc has a 52-week low of 0.50 and a 52-week high of $3.22. The business's 50-day...